Filing a provisional patent application was introduced into U.S. patent law in 1994. The ability to file a provisional application was widely applauded at the time and filing provisional applications ...

Patent applicants often file provisional applications at the United States Patent and Trademark Office (USPTO) to secure a priority date before filing a full-blown utility patent application for their ...

I am a big fan of inventors using provisional applications as a first step toward obtaining a utility patent. Indeed, provisional patent applications provide many benefits. Provisional applications ...

As part of the effort to harmonize global patent systems, the United States introduced the provisional patent application in 1995 as part of the GATT Uruguay Round agreement. The provisional patent ...

I think inventors should try writing their own provisional patent applications, even if they end up hiring a patent attorney to write the final version. Why? Because committing your thoughts to paper ...

“If you cannot get a confidentiality agreement signed you absolutely must file a patent application first, and you really should have professional help doing that if you can afford it.” As mentioned ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. You have a great idea for an invention, and you think it is ...

While the United States is alternately lauded and slammed for its characteristic unilateralism, in at least one area — intellectual property (IP) policy — the US is no longer alone, as Israel has ...

The Situation: Provisions of the Action Plan for the Growth and Transformation of Enterprises Act ("PACTE Act") concerning the newly created provisional patent application and the strengthening of the ...

JUPITER, Fla.--(BUSINESS WIRE)--BioCurity, a private preclinical biotech, is developing oncology supportive care drugs that are designed to prevent or mitigate some of the side effects associated with ...

Nutriband files provisional patent application to enhance its AVERSA™ transdermal abuse deterrent technology being developed for patches containing opioids and stimulants with a potential for abuse.